Pricing
  1. US-listed companies
  2. SOLENO THERAPEUTICS INC
  3. Financials
  4. Net income

SOLENO THERAPEUTICS INC (SLNO)

Market cap
$1.9B
P/E ratio
SummaryFinancials
Period EndNet income (Million USD)YoY (%)
Dec 31, 2024-176+351.04%
Dec 31, 2023-39+62.00%
Dec 31, 2022-24-22.14%
Dec 31, 2021-31+25.45%
Dec 31, 2020-25-19.94%
Dec 31, 2019-31+130.78%
Dec 31, 2018-13-14.89%
Dec 31, 2017-16+29.86%
Dec 31, 2016-12-24.16%
Dec 31, 2015-16+14.66%
Dec 31, 2014-14

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat